Axsome Therapeutics, Inc.AXSMNASDAQ
Loading
Year-over-year book value per share growth
Latest
18.32%
↓ 84% vs avg
Percentile
P82
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
111.27%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 18.32% |
| Q3 2025 | -0.28% |
| Q2 2025 | 35.76% |
| Q1 2025 | -7.31% |
| Q4 2024 | -39.13% |
| Q3 2024 | -10.74% |
| Q2 2024 | -28.86% |
| Q1 2024 | -24.68% |
| Q4 2023 | -29.46% |
| Q3 2023 | -10.41% |
| Q2 2023 | 148.52% |
| Q1 2023 | 1.88% |
| Q4 2022 | -33.17% |
| Q3 2022 | 870.19% |
| Q2 2022 | 1.41% |
| Q1 2022 | -7.34% |
| Q4 2021 | -63.49% |
| Q3 2021 | -40.34% |
| Q2 2021 | -26.14% |
| Q1 2021 | -15.56% |
| Q4 2020 | -15.96% |
| Q3 2020 | -12.80% |
| Q2 2020 | -1.33% |
| Q1 2020 | -18.06% |
| Q4 2019 | 2496.02% |
| Q3 2019 | -72.43% |
| Q2 2019 | 36.67% |
| Q1 2019 | 1574.25% |
| Q4 2018 | 11.28% |
| Q3 2018 | -89.62% |
| Q2 2018 | -44.94% |
| Q1 2018 | -28.47% |
| Q4 2017 | -3.16% |
| Q3 2017 | -26.12% |
| Q2 2017 | -35.65% |
| Q1 2017 | 33.07% |
| Q4 2016 | -23.48% |
| Q3 2016 | -19.26% |
| Q2 2016 | -15.35% |
| Q1 2016 | -33.10% |